Assignee
TRUEBINDING INC
US·4 granted patents·14 pending applications·9 citations·filing 2018–2025
Top patents by PatentIndex Score
18 records- 0191US11427638B2Anti-Gal3 antibodies and uses thereofTRUEBINDING INC·Filed 2021·Granted Aug 30, 2022·5 cites·5 claims
- 0287US12497458B2Anti-GAL3 antibodies and uses thereofTRUEBINDING INC·Filed 2022·Granted Dec 16, 2025·1 cites·5 claims
- 0387US12227567B2Treating cancer by blocking the interaction of TIM-3 and its ligandTRUEBINDING INC·Filed 2018·Granted Feb 18, 2025·2 cites·15 claims
- 0480US2024182564A1Treating cancer by blocking the interaction of tim-3 and its ligandTRUEBINDING INC·Filed 2023·Application pending·0 cites
- 0578US12281166B2Methods of treating inflammatory diseases by blocking Galectin-3TRUEBINDING INC·Filed 2021·Granted Apr 22, 2025·1 cites·9 claims
- 0673US2025171539A1Treating cancer by blocking the interaction of tim-3 and its ligandTRUEBINDING INC·Filed 2025·Application pending·0 cites
- 0761US2024158512A1Anti-gal3 antibody formulations and methods of use thereofTRUEBINDING INC·Filed 2023·Application pending·0 cites
- 0860US2023036181A1Anti-gal3 antibodies and methods of useTRUEBINDING INC·Filed 2022·Application pending·0 cites
- 0957US2025243282A1Methods of treating inflammatory diseases by blocking galectin-3TRUEBINDING INC·Filed 2025·Application pending·0 cites
- 1057US2024352131A1Methods of treating eye diseaseTRUEBINDING INC·Filed 2024·Application pending·0 cites
- 1150US2025145722A1Anti-gal3 antibodies and methods of useTRUEBINDING INC·Filed 2025·Application pending·0 cites
- 1250US2022411514A1Anti-gal3 antibodies and methods of use for insulin resistanceTRUEBINDING INC·Filed 2022·Application pending·0 cites
- 1349US2025026838A1Methods of preventing protein aggregationTRUEBINDING INC·Filed 2022·Application pending·0 cites
- 1447US2023279120A1Methods of treating or inhibiting cardiovascular diseasesTRUEBINDING INC·Filed 2022·Application pending·0 cites
- 1546US2023094463A1Antibodies that disrupt the interaction of gal3 and insulin receptor or integrins and methods of use thereofTRUEBINDING INC·Filed 2020·Application pending·0 cites
- 1646US2022281973A1Antibodies and blocking the interaction of vista and its binding partnerTRUEBINDING INC·Filed 2020·Application pending·0 cites
- 1743US2021363255A1Methods and compositions for blocking interaction between non-glycosylated pd-1 polypeptidesTRUEBINDING INC·Filed 2019·Application pending·0 cites
- 1842US2021085785A1Treating cancer by blocking the interaction of vista and its binding partnerTRUEBINDING INC·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →